Advertisement

Dow rises 337 points as Senate announces debt ceiling deal

1/5
Dow rises 337 points as Senate announces debt ceiling deal
The Dow Jones Industrial Average gained 337 points on Thursday after Senate lawmakers announced a deal to extend the debt ceiling. File Photo by John Angelillo/UPI | License Photo

Oct. 7 (UPI) -- The Dow Jones Industrial Average rose more than 300 points Thursday as stocks continued to rally in reaction to Congress reaching a deal to extend the debt ceiling.

The blue-chip index gained 337.95 points, or 0.98%, while the S&P 500 rose 0.83% and the Nasdaq Composite closed the day up 1.05%.

Advertisement

Stocks were largely buoyed by Senate Democratic leader Chuck Schumer, D-N.Y., announcing that Senate leaders reached an agreement Thursday on a temporary extension of the debt limit with a vote possible as soon as Thursday evening.

"The debt ceiling is one of many factors right now that we think are causing these gyrations in the markets," Yung-Yu Ma, chief investment strategist for BMO Wealth Management, told Yahoo Finance, amid a volatile start to October. "Certainly the market will take some comfort when there is a deal, when it is more formalized."

RELATED United Airlines to add 3,500 daily flights in December

Tech shares continued their rally after dragging markets down earlier in the month due to rising treasury yields. Twitter stock rose 4.37% and chipmakers also got a boost as AMD gained 2.71% Nvidia rose 1.81%.

Shares of Rocket Lab USA shot up 10.43% after the company announced late Wednesday that its Electron rocket was selected by NASA to launch the space agency's Advanced composite Solar Sail System, or ACS3, in mid-2022.

Advertisement

Markets also got a boost as the Labor Department reported that unemployment claims per week has fallen to 326,000 last week, down almost 40,000 from the previous week. It was the first decline in four weeks.

RELATED GM's self-driving subsidiary Cruise aims for fleet of 1M vehicles by 2030

Friday will also yield a jobs report that could influence the Federal Reserve's decision on whether to scale down its pandemic bond purchasing program.

RELATED Pfizer seeks emergency FDA approval for COVID-19 vaccine in children 5-11

Latest Headlines

Advertisement
Advertisement

Follow Us

Advertisement